In its May edition of Peer Review Notes, the US National Institutes of Health's Center for Scientific Review reiterates how it defines a new application, in the context of an unsuccessful A1 resubmission. "A new application is expected to be substantially different in content and scope, with more significant differences than are normally encountered in a resubmitted application," CSR notes.